Is your child currently experiencing moderately to severely active IBD flare-ups? Local CD clinical research is testing a potential new medication to see if it may reduce diarrhea with blood, abdominal cramps, diarrhea, malnutrition, and/or canker sores associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the CD clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

Is your child currently experiencing Crohn’s flare-ups? Local clinical research is testing a potential new medication to see if it may reduce diarrhea with blood, weight loss, diarrhea, malnutrition, and/or liver disease associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce fever, unexplained weight loss, bloody stool, malnutrition, and/or liver disease associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

Is your child currently experiencing ulcerative colitis flare-ups? Local CD trial is testing a potential new medication to see if it may reduce diarrhea with blood, iron deficiency, cramps, malnutrition, and/or canker sores associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2–17 years of age to join a clinical research study to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or Inflammatory bowel disease (including associated symptoms such as diarrhea with blood, kidney stones, bloody stool, malnutrition and/or liver disease), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce abdominal cramping, loss of appetite, diarrhea, frequent fevers, and/or liver disease associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children 2 to 17 years old to join a clinical research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or Inflammatory bowel disease (including associated symptoms such as tiredness, loss of appetite, constant need to poop, frequent fevers and/or eye pain), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease clinical research is testing a potential new medication to see if it may reduce abdominal pain or cramping, iron deficiency, bloody stool, weight loss, and/or eye pain associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

Is your child currently experiencing CD and UC flare-ups? Local CD trial is testing a potential new medication to see if it may reduce weight loss, diarrhea, diarrhea, malnutrition, and/or anemia associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease (CD) research study to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or moderate to severe IBD (including associated symptoms such as abdominal pain and cramps, weight loss, diarrhea, chronic fatigue and/or liver disease), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.